Reportlinker.com

Reportlinker.com

March 27, 2008 06:02 ET

Focus on the World Carotid Stents Market

LONDON, UNITED KINGDOM--(Marketwire - March 27, 2008) - Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

World Carotid Stents Market

This report analyzes the worldwide markets for Carotid Stents in Thousand Units and US$ Million. The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for each region for the period of 2004 through 2012. The report profiles 10 companies including many key and niche players worldwide such as Abbott Vascular, Boston Scientific Corporation, ev3, Inc., Johnson & Johnson, Cordis Corporation, Kensey Nash Corporation, and Medtronic, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-2

Product Definitions and Scope of Study I-3

Carotid Stents I-3

II. EXECUTIVE SUMMARY

1. Global Market Overview and Analysis II-1

Carotid Stents - A Nascent Market II-1

Current and Future Analysis II-1

US - Picking Pace II-1

2. Market Dynamics II-2

Factors Driving Carotid Stents Market II-2

Clinical Trials & Regulatory Approvals to Accelerate Adoption II-2

Broader Application of CAS II-2

Benefiting From Less-Invasive Nature of Procedure II-2

Acceptance by Various Medical Specialties II-2

Market Challenges II-3

Absence of Sufficient Clinical Data II-3

Surgeons Wary of High-Risk CAS Procedures II-3

Reimbursement Coverage Issue Hurdles Widespread Adoption II-3

Fighting for CAS Domain II-3

Training and Certification of Surgeons - A Major Hurdle II-4

Stenting Procedure for Transient Ischemic Attacks - A Continuing Dilemma II-4

3. Competitive Scenario II-5

Table 1: Worldwide Carotid Stents Market (2006-2007E): Market Share of Leading Players by Revenues for Boston Scientific, Abbott Vascular/Guidant, Johnson & Johnson/Cordis, Medtronic and Others (includes corresponding Graph/Chart) II-5

4. Product Overview II-6

Carotid Stents - An Introduction II-6

How is Carotid Stenting Helpful? II-6

Carotid Stents - A Viable Alternative to Surgical Procedures II-6

Carotid Stenting Lowers Depression Symptoms!!! II-7

Embolic Protection Devices II-7

Filter-Based EPD Systems II-7

Balloon Occlusion Devices II-7

Basic Carotid Stents Products II-8

Stent Design II-8

Carotid Stents of Major Companies Available in the Market II-8

Carotid Stents Under Development II-9

Diagnosis of Carotid Artery Blockage II-9

Eligibility Criteria for Carotid Stenting Procedure II-10

Potential Candidates for Carotid Stenting II-10

Patients with High Surgical Risk II-10

Non-Candidates for Carotid Stenting II-10

Risk Factors Associated with Carotid Stenting Procedures II-10

Carotid Artery Stenting (CAS) - The Procedure II-11

Catheter Insertion Via Femoral Artery II-11

Advantages of the Procedure II-12

Post-Stenting Complications II-12

5. Overview of Cardiac Diseases II-13

Cerebrovascular Disease II-13

Carotid Artery Disease II-13

Major Symptoms II-13

Carotid Artery Stenosis II-13

Atherosclerosis II-14

Treatment Procedures for Carotid Artery Disease II-14

Carotid Endarterectomy (CEA) II-14

Drawbacks of CEA Procedure II-14

Carotid Artery Stenting (CAS) II-15

CAS Versus CEA II-15

Table 2: Worldwide Carotid Interventions (2006-2008E)): Percentage Breakdown of Number of Procedures for Carotid Endarterectomy and Carotid Stenting (includes corresponding Graph/Chart) II-16

Comparative Study of CAS and CEA Devices II-16

Benefits of CAS over CEA II-16

Drawbacks for CAS Penetration II-17

Risks Associated with CEA and CAS II-17

6. Major Clinical Trials/Studies II-18

Clinical Trials - Key to Higher Adoption of Carotid Stents II-18

Major Clinical Trials & Stent Devices Used II-18

Guidant's CAPTURE Study II-19

CAPTURE Study Results Hold Promise for Asymptomatic Patients II-19

Boston Scientific's BEACH Trial II-20

Abbott's ACT I Trial II-20

CREST Clinical Trial II-20

J&J's SAPPHIRE Clinical Trial II-21

SAPPHIRE Study Proves Effectiveness of CAS in High-Risk Patients II-21

Other Trials II-21

Medtronic's MAVErIC Trials Validate the Efficiency of Exponent Carotid Stent II-21

University of Massachusetts Conduct CAS Efficacy Study in Elderly Patients II-22

CaRESS Study II-22

7. Product Launches/Approvals II-23

KNC Obtains Expanded CE Mark Clearance for TriActiv(R) ProGuard(TM) II-23

FDA Approves Protege(R) RX Carotid Stent from ev3 II-23

Abbott Introduces Emboshield(R) PRO Embolic Protection System in Europe II-24

Cordis Gains FDA Approval for PRECISE(R) & ANGIOGUARD(R) Devices II-24

Medtronic Obtains CE Mark Approval for Exponent(R) RX Carotid Stent II-24

FDA Approves Boston Scientific's FilterWire EZ(TM) Embolic Protection System II-25

Abbott's Xact(R) Carotid Stent Receives FDA Approval II-25

EndoTex's NexStent(TM) Receives CE Mark Approval II-25

KNC Seeks FDA Approval for TriActiv LFX Trial II-25

Guidant's RX ACCULINK(TM) Carotid Stent System Gets FDA Clearance II-26

ev3's Protege GPS Receives CE Mark Approval II-26

Medtronic's Interceptor(R) PLUS Carotid Filter System Receives CE Mark Approval II-26

Guidant Unveils RX Accunet Embolic Protection System in European Market II-26

Guidant Rolls Out ACCULINK(TM) Carotid Stent System for European Market II-27

8. Recent Industry Activity II-28

Boston Scientific Acquires EndoTex II-28

Boston Scientific and Guidant Merge Operations; Abbott Acquires Guidant's Vascular Business II-28

Lumen Commences EPIC Feasibility Study II-29

Boston Scientific Exclusively Distributes EndoTex's NexStent(TM) Carotid Stent II-29

9. Focus on Select Players II-30

Abbott Vascular (USA) II-30

Boston Scientific Corporation (USA) II-30

ev3, Inc. (USA) II-31

Johnson & Johnson (USA) II-31

Cordis Corporation (USA) II-31

Kensey Nash Corporation (USA) II-32

Medtronic, Inc. (USA) II-32

10. Global Market Perspective II-33

Table 3: World Recent Past, Current & Future Analysis for Carotid Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Number of Carotid Stent Procedures in Thousands for Years 2004 through 2012 (includes corresponding Graph/Chart) II-33

Table 4: World 9-Year Perspective for Carotid Stents by Geographic Region - Percentage Breakdown by Number of Carotid Stent Procedures for US, Europe and Rest of World Markets for Years 2004, 2007 & 2012 (includes corresponding Graph/Chart) II-33

Table 5: World Recent Past, Current & Future Analysis for Carotid Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2012 (includes corresponding Graph/Chart) II-34

Table 6: World 9-Year Perspective for Carotid Stents by Geographic Region - Percentage Breakdown by Annual Revenues for US, Europe and Rest of World Markets for Years 2004, 2007 & 2012 (includes corresponding Graph/Chart) II-34

III. MARKET

1. The United States III-1

A.Market Analysis III-1

Overview III-1

Current and Future Analysis III-1

Factors Affecting Growth III-1

Reimbursement Scenario for CAS III-1

Restricted Reimbursement Coverage Limits CAS Penetration III-2

CMS Proposes Expanded Reimbursement Coverage for Carotid Stenting III-2

Absence of Regulatory Approvals - A Major Challenge III-3

Clinical Trials - Key to Higher Adoption of Carotid Stents III-3

Latent Demand III-3

Key Statistics III-3

Major Carotid Stents & EPDs in the Market III-3

US Carotid Stents Market - A Gradual Growth III-4

Table 7: Carotid Interventions in the US (2006-2008): Percentage Breakdown of Number of Procedures by Carotid Endarterectomy and Carotid Stenting (includes corresponding Graph/Chart) III-5

Trends and Issues III-5

Convenience in Deployment & Use - Critical for Higher Adoption III-5

Rapid Exchange Capabilities Facilitate Effective Control Over Procedures III-5

Carotid Stents Assume the Role of Memory Boosters III-5

Competitive Landscape III-6

Table 8: US Carotid Stents Market (2006-2007): Market Share of Leading Players by Revenues for Boston Scientific, Guidant, Cordis/J&J, Medtronic and Others (includes corresponding Graph/Chart) III-6

Product Launches/Approvals III-7

Strategic Corporate Developments III-9

Focus on Select Players III-10

Abbott Vascular III-10

Boston Scientific Corporation III-11

ev3, Inc. III-11

Johnson & Johnson III-12

Cordis Corporation III-12

Kensey Nash Corporation III-12

Medtronic, Inc. III-13

B.Market Analysis III-13

Table 9: US Recent Past, Current & Future Analysis for Carotid Stents Market Independently Analyzed with Annual Number of Carotid Stent Procedures in Thousands for Years 2004 through 2012 (includes corresponding Graph/Chart) III-13

Table 10: US Recent Past, Current & Future Analysis for Carotid Stents Market Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2012 (includes corresponding Graph/Chart) III-14

2. Europe III-15

A.Market Analysis III-15

Current and Future Analysis III-15

European Carotid Stents Market - An Overview III-15

ELOCAS Study III-15

CEA Versus CAS III-15

Table 11: European Vascular Interventions Market (2004-2006E): Percentage Breakdown by Number of Procedures for Carotid Artery Stenting and Carotid Endarterectomy (includes corresponding Graph/Chart) III-16

Product Launches/Approvals III-16

Strategic Corporate Development III-18

B.Market Analytics III-19

Table 12: European Recent Past, Current & Future Analysis for Carotid Stents Market Independently Analyzed with Annual Number of Carotid Stent Procedures in Thousands for Years 2004 through 2012 (includes corresponding Graph/Chart) III-19

Table 13: European Recent Past, Current & Future Analysis for Carotid Stents Market Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2012 (includes corresponding Graph/Chart) III-19

3. Rest of World III-20

A.Market Analysis III-20

Current and Future Analysis III-20

Carotid Stenting Scenario in India III-20

B.Market Analytics III-21

Table 14: Rest of World Recent Past, Current & Future Analysis for Carotid Stents Market Independently Analyzed with Annual Number of Carotid Stent Procedures in Thousands for Years 2004 through 2012 (includes corresponding Graph/Chart) III-21

Table 15: Rest of World Recent Past, Current & Future Analysis for Carotid Stents Market Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2012 (includes corresponding Graph/Chart) III-21

IV. COMPETITIVE LANDSCAPE

To order this report: World Carotid Stents Market

More market research reports here!

Contact Information